NCT04042844 - A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Lumbar Disc Disease

Interventions

BIOLOGICAL

BRTX-100

Hypoxic cultured mesenchymal stem cells (MSCs) from autologous bone marrow with autologous platelet lysate.

DRUG

Saline

Sodium Chloride (0.9%) intravenous infusion preparation is a sterile and non-pyrogenic solution

Trial Locations (19)

10022

RECRUITING

Northwell Health, New York

23235

RECRUITING

Virginia iSpine Physicians, Richmond

27103

RECRUITING

The Center of Clinical Research, LLC, Winston-Salem

32257

RECRUITING

Coastal Health, Jacksonville

32789

RECRUITING

Conquest Research, Winter Park

33306

WITHDRAWN

Cantor Spine Institute, Fort Lauderdale

33603

RECRUITING

Tampa Pain Relief Center, Tampa

33614

RECRUITING

Florida Pain Relief Center, Tampa

33709

RECRUITING

Pain Relief Centers, St. Petersburg

35235

WITHDRAWN

Alabama Clinical Therapeutics, LLC, Birmingham

44195

RECRUITING

Cleveland Clinic, Cleveland

73013

WITHDRAWN

Clinical Investigations LLC, Edmond

75701

WITHDRAWN

Precision Spine Care, Tyler

77008

RECRUITING

NCP Center for Clinical Research and Innovation, Houston

78758

RECRUITING

Science Connections, Austin

80111

RECRUITING

Denver Back Pain Specialists, LLC, Greenwood Village

90403

RECRUITING

Source Healthcare, Santa Monica

94598

RECRUITING

Boomerang Healthcare, Walnut Creek

29406,

WITHDRAWN

Coastal Carolina Research Center, North Charleston